I survived breast cancer and medical trauma, but the road was brutal. Fifteen years later, I’m alive, scarred and still ...

Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2 ...

The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and ...

The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds explained.

Imlunestrant Alone or With Verzenios Improved PROs in Advanced Breast Cancer ...

Five years after my transplant for leukemia, I’m learning to focus on gratitude despite daily struggles, remembering that ...

Michelle Kirschner discusses the how patients can foster a strong network of supporters from diagnosis through survivorship.

Natalie Schnaitmann discusses the importance of self-advocacy and access to second opinions when symptoms are dismissed among ...

Let’s get straight to the point: a good nurse can change your experience with cancer and cancer treatment.

The first patient has been dosed in the phase 3 TERZO trial of Copiktra for relapsed or refractory nodal T-follicular helper ...

It is important to understand why it is vital that patients and survivors of cancer take steps to reduce the body’s burden ...

Zilovertamab vedotin plus R-GemOx showed a 56.3% objective response rate in relapsed/refractory DLBCL patients, with a 50% complete response rate at the recommended phase 2 dose. The median duration ...